BRIDGEWAY CAPITAL MANAGEMENT, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 1 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$339,000
-37.3%
654,200
-8.4%
0.01%
-27.3%
Q2 2020$541,000
+4.2%
714,200
+40.3%
0.01%
-8.3%
Q1 2020$519,000
-46.4%
509,200
-18.4%
0.01%
-7.7%
Q4 2019$968,000
+1.1%
624,200
+18.0%
0.01%0.0%
Q3 2019$957,000
+72.1%
529,000
+56.0%
0.01%
+85.7%
Q2 2019$556,000
-8.4%
339,0000.0%0.01%
-12.5%
Q1 2019$607,000
+214.5%
339,000
+232.7%
0.01%
+166.7%
Q4 2018$193,000
-47.0%
101,9000.0%0.00%
-25.0%
Q3 2018$364,000
+71.7%
101,9000.0%0.00%
+100.0%
Q2 2018$212,000
+71.0%
101,9000.0%0.00%
+100.0%
Q1 2018$124,000101,9000.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders